These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16816452)

  • 1. Use of ticlopidine and cilostazol after intracoronary drug-eluting stent placement in a patient with previous clopidogrel-induced thrombotic thrombocytopenic purpura: a case report.
    Patel TN; Kreindel M; Lincoff AM
    J Invasive Cardiol; 2006 Jul; 18(7):E211-3. PubMed ID: 16816452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention.
    Bennett CL; Davidson CJ; Raisch DW; Weinberg PD; Bennett RH; Feldman MD
    Arch Intern Med; 1999 Nov; 159(21):2524-8. PubMed ID: 10573042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and ticlopidine after routine coronary stenting: the gold standard as of 1999.
    McCullough PA; Marks KR
    J Thromb Thrombolysis; 1999 Jun; 7(3):233-9. PubMed ID: 10373716
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of cilostazol versus ticlopidine therapy after stent implantation.
    Park SW; Lee CW; Kim HS; Lee HJ; Park HK; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 1999 Sep; 84(5):511-4. PubMed ID: 10482146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after coronary artery stenting.
    Manor SM; Guillory GS; Jain SP
    Pharmacotherapy; 2004 May; 24(5):664-7. PubMed ID: 15162901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis.
    Lee SW; Park SW; Hong MK; Kim YH; Lee BK; Song JM; Han KH; Lee CW; Kang DH; Song JK; Kim JJ; Park SJ
    J Am Coll Cardiol; 2005 Nov; 46(10):1833-7. PubMed ID: 16286167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: a meta-analysis of randomized trials.
    Schleinitz MD; Olkin I; Heidenreich PA
    Am Heart J; 2004 Dec; 148(6):990-7. PubMed ID: 15632883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
    Makkar K; Wilensky RL; Julien MB; Herrmann HC; Spinler SA
    Ann Pharmacother; 2006 Jun; 40(6):1204-7. PubMed ID: 16684808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.
    Steinhubl SR; Tan WA; Foody JM; Topol EJ
    JAMA; 1999 Mar; 281(9):806-10. PubMed ID: 10071001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
    Suh JW; Lee SP; Park KW; Lee HY; Kang HJ; Koo BK; Cho YS; Youn TJ; Chae IH; Choi DJ; Rha SW; Bae JH; Kwon TG; Bae JW; Cho MC; Kim HS
    J Am Coll Cardiol; 2011 Jan; 57(3):280-9. PubMed ID: 21232664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
    Lee BK; Lee SW; Park SW; Lee SW; Park DW; Kim YH; Lee CW; Hong MK; Kim JJ; Jang S; Chi HS; Park SJ
    Am J Cardiol; 2007 Aug; 100(4):610-4. PubMed ID: 17697815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute coronary stent thrombosis in a patient developing clopidogrel associated thrombotic thrombocytopenic purpura.
    von Mach MA; Eich A; Weilemann LS; Münzel T
    Heart; 2005 Feb; 91(2):e14. PubMed ID: 15657204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
    Yoon Y; Shim WH; Lee DH; Pyun WB; Kim IJ; Jang Y; Cho SY
    Am J Cardiol; 1999 Dec; 84(12):1375-80. PubMed ID: 10606107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents.
    Müller C; Büttner HJ; Petersen J; Roskamm H
    Circulation; 2000 Feb; 101(6):590-3. PubMed ID: 10673248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting.
    Steinhubl SR; Topol EJ
    J Thromb Thrombolysis; 1999 Jun; 7(3):227-31. PubMed ID: 10373712
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura.
    Lotta LA; Mancini I; Tuana G; Musallam KM; Peyvandi F
    J Thromb Thrombolysis; 2012 Oct; 34(3):416-8. PubMed ID: 22450533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic thrombocytopenic purpura: a rare but potential life-threatening complication following ticlopidine administration.
    Jamar S; Vanderheyden M; Janssens L; Hermans L; Jamar R; Verstreken G
    Acta Cardiol; 1998; 53(5):285-6. PubMed ID: 9922807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel-associated thrombotic thrombocytopenic purpura presenting with coronary artery thrombosis.
    Oo TH
    Am J Hematol; 2006 Nov; 81(11):890-1. PubMed ID: 16804940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.